Q1 2025 Earnings Estimate for Aspen Aerogels, Inc. (NYSE:ASPN) Issued By Seaport Res Ptn

Aspen Aerogels, Inc. (NYSE:ASPN) – Research analysts at Seaport Res Ptn reduced their Q1 2025 earnings per share estimates for shares of Aspen Aerogels in a report released on Thursday, October 10th. Seaport Res Ptn analyst T. Curran now anticipates that the construction company will post earnings of $0.04 per share for the quarter, down from their previous forecast of $0.11. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.21 per share. Seaport Res Ptn also issued estimates for Aspen Aerogels’ Q2 2025 earnings at $0.10 EPS, Q3 2025 earnings at $0.14 EPS and Q4 2025 earnings at $0.14 EPS.

Aspen Aerogels (NYSE:ASPN) last issued its earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The company had revenue of $117.80 million for the quarter, compared to the consensus estimate of $101.99 million. During the same period in the previous year, the firm earned ($0.22) earnings per share. Aspen Aerogels’s quarterly revenue was up 144.4% compared to the same quarter last year.

Other research analysts have also issued research reports about the stock. B. Riley raised shares of Aspen Aerogels to a “strong-buy” rating in a research note on Tuesday, June 25th. HC Wainwright increased their price objective on shares of Aspen Aerogels from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. Benchmark reiterated a “buy” rating and issued a $14.00 target price on shares of Aspen Aerogels in a report on Thursday, August 8th. Barclays began coverage on Aspen Aerogels in a research note on Tuesday, August 6th. They set an “overweight” rating and a $27.00 price target on the stock. Finally, Roth Mkm reaffirmed a “buy” rating and issued a $36.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, August 21st. One research analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $29.70.

Aspen Aerogels Trading Down 1.4 %

ASPN opened at $22.43 on Monday. The business’s 50 day moving average price is $25.84 and its 200 day moving average price is $24.33. The company has a debt-to-equity ratio of 0.23, a quick ratio of 2.82 and a current ratio of 3.46. The stock has a market capitalization of $1.71 billion, a PE ratio of -50.98 and a beta of 2.16. Aspen Aerogels has a one year low of $6.62 and a one year high of $33.15.

Institutional Investors Weigh In On Aspen Aerogels

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Driehaus Capital Management LLC increased its position in Aspen Aerogels by 130.4% during the second quarter. Driehaus Capital Management LLC now owns 2,156,789 shares of the construction company’s stock worth $51,439,000 after buying an additional 1,220,724 shares during the period. American Century Companies Inc. increased its holdings in shares of Aspen Aerogels by 562.3% in the 2nd quarter. American Century Companies Inc. now owns 770,729 shares of the construction company’s stock valued at $18,382,000 after acquiring an additional 654,350 shares during the period. Millennium Management LLC acquired a new position in shares of Aspen Aerogels in the 2nd quarter valued at $9,339,000. Hood River Capital Management LLC raised its position in Aspen Aerogels by 12.2% in the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock valued at $58,088,000 after purchasing an additional 357,895 shares during the last quarter. Finally, Renaissance Technologies LLC acquired a new stake in Aspen Aerogels during the 2nd quarter worth $8,340,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of Aspen Aerogels stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Aspen Aerogels news, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at $626,610.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Donald R. Young sold 63,355 shares of the stock in a transaction dated Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the transaction, the chief executive officer now owns 483,640 shares in the company, valued at approximately $14,523,709.20. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by corporate insiders.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.